Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ASRS 2019Double-Barreled Biologic for Diabetic Retinopathy EmergingTrial results for the first biologic to target both the VEGF and Ang-2 pathways designed for less frequent injections than current options will be presented at the upcoming retina conference.
ADA 2019Read clinically focused news coverage of key developments from ADA 2019
Medscape Diabetes & Endocrinology, May 30, 2019
Is CREDENCE a Game Changer for Diabetic Nephropathy?The medical community is marveling at the results of the CREDENCE trial. But can one study really change clinical practice? Perry Wilson shares his thoughts.
